Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1/2, Multicenter, Open-Label, Dose-Escalation, Safety, Tolerability, and Clinical Activity Study of a Single Dose of JAG201 Gene Therapy Delivered Via Intracerebroventricular Administration in Participants With SHANK3 Haploinsufficiency
This is a Phase 1/2, first in human, open-label, dose-escalation study to evaluate the safety, tolerability, and clinical activity of a single dose of JAG201 a…
SHANK3 HaploinsufficiencyPhelan-McDermid Syndrome
Jaguar Gene Therapy, LLCNCT06662188
Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders …
16P11.2 Deletion Syndrome16p11.2 Duplications1Q21.1 Deletion+181 more